Primary outcome: disease-specific health-related quality of life
After 12 months’ follow-up, the VEINES-QOL/Sym scores for patients in the SAP group were not significantly different from those of patients treated with TAP (
Values are means with 95% confidence intervals. VEINES-QOL/Sym, VEnous INsufficiency Epidemiological and Economic Study Quality of Life/Symptoms; SAP, isolated ambulatory phlebectomy with or without delayed endovenous truncal ablation; TAP, thermal ablation with concomitant phlebectomy.Quality-of-life measurementsValues are mean (95% c.i.). SAP, isolated ambulatory phlebectomy with or without delayed endovenous truncal ablation; TAP, thermal ablation with concomitant phlebectomy; HRQoL, health-related qualtiy of life; VEINES-QOL/Sym outcomes VEnous INsufficiency Epidemiological and Economic Study Quality of Life/Symptoms; EQ-5D™, EuroQol Five Dimensions; EQ-VAS, EuroQol visual analogue scale. VEINES-QOL/Sym outcomes were analysed in a multilevel repeated-measures model. EQ-5D™ and EQ-VAS scores were analysed using an independent 